Anna Apostolopoulou MD

Fellowship- Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, 2016-2018Residency- Internal Medicine, Lincoln Medical and Mental Health Center, New York, 2013-2016

Amit Kohli, M.D., is a Clinical Attending and Assistant Professor of Clinical Neurology at New York Presbyterian/Weill Cornell Medical College specializing in Multiple Sclerosis and related autoimmune disorders. The goal of his practice is to provide compassionate care which places the patient as a person first while delivering the highest levels of expertise available in diagnostic and therapeutic strategies. Having trained extensively with a focus on autoimmune conditions of the central nervous system, Dr. Kohlis vision for holistic care is based on years of experience in finding solutions for both the everyday and long-term needs of patients with autoimmune and demyelinating diseases. His clinical and research focus is on the application of cutting-edge strategies and tools for the diagnosis of conditions such as Multiple Sclerosis (MS), NMO, MOG Antibody Disease, ADEM, Optic Neuritis, Transverse Myelitis, Neurosarcoidosis, and others.Dr. Kohli earned his undergraduate degree in biology with a concentration in neuroscience from the University of Chicago, and his M.D. from the Zucker School of Medicine at Northwell Health. He completed his residency in Neurology at The Mount Sinai Hospital on the upper east side of New York and continued on to complete his fellowship in Multiple Sclerosis at the Corrine Goldsmith Dickinson Center for MS at Mount Sinai. While at the CGD Center, Dr. Kohlipracticed under the mentorship of Drs. Fred Lublin, Aaron Miller, Stephen Krieger, and others, helped to run clinical trials in progressive MS, and researched diagnostic strategies to improve the detection of cortical lesionsin Multiple Sclerosis, which were presented nationally.At Weill Cornells Judith Jaffe Multiple Sclerosis Center, Dr. Kohli engages in research on state-of-the-art imaging techniques to identify and treat inflammation in MS. He plans to participate in clinical trials to find better treatment options for patients living with Multiple Sclerosis.